Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head and Neck Cancer

Condition:   Head and Neck Squamous Cell Carcinoma Interventions:   Procedure: Computed Tomography;   Procedure: Lymphoscintigraphy;   Drug: Panitumumab-IRDye800;   Other: Pharmacological Study;   Procedure: Single Photon Emission Computed Tomography;   Radiation: Technetium Tc 99m-labeled Tilmanocept Sponsors:   Eben Rosenthal;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials